New York Life Investment Management’s Cidara Therapeutics CDTX Stock Holding History

New York Life Investment Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,935	Closed	-$3.52M	–	789
2025 Q4	$3.52M	Buy	+15,935	New	+$2.58M	0.03%	395

New York Life Investment Management's CDTX Position: Q1 2026 in Review

New York Life Investment Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 15,935 shares — an estimated $3.52M sold.

New York Life Investment Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $3.52M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

New York Life Investment Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
New York Life Investment Management sold 15,935 Cidara Therapeutics shares in Q1 2026, an estimated $3.52M.
New York Life Investment Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
New York Life Investment Management's Cidara Therapeutics position peaked at $3.52M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.